DOCSLIB.ORG

Immune Cell Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Immune cell guide Antibodies Human and mouse antigens Full spectrum cell analysis Each cell holds a mystery waiting to be solved. At Thermo Fisher Scientific, we are focussed on accelerating your science and advancing meaningful discoveries by providing a comprehensive suite of solutions for the analysis of cells and their functions. Our innovative products include the Invitrogen™ Attune™ NxT Flow Cytometer, eBioscience™ flow cytometry antibodies and Super Bright conjugates, PrimeFlow™ gene expression assays, and functional assays. When you are on your quest for significant breakthroughs, we know that you never settle for average, and neither will we. Abbreviations Contents Act Activated RBC Red blood cells ASV Alternative splice variants RTK Receptor tyrosine kinase ADCC Antibody-dependent cellular cytotoxicity Tfh Folicular T helper cells B cell markers 4 AML Acute myeloid leukemia Th T helper cells APC Antigen presenting cells TF Transcription factor CD4 T cell markers 6 BM Bone marrow TM Transmembrane CCRSF Complement component receptor superfamily TM12SF 12-transmembrane spanning protein superfamily CD Cluster of differentiation TM4SF 4-transmembrane spanning protein superfamily CD8 T cell markers 8 CHO Carbohydrate moiety TM7SF 7-transmembrane spanning protein superfamily CNS Central nervous system TNFRSF TNF receptor superfamily Dendritic cell markers 10 CRSF Cytokine receptor superfamily TNFSF TNF superfamily CTL Cytotoxic T lymphocytes DC Dendritic cells Granulocyte markers 12 ECM Extracellular matrix Format abbreviations Endoth Endothelial cells FG purified Functional grade purified Macrophage/monocyte 14 Epith Epithelial cells (sterile and azide-free) ESC Embryonic stem cells FG biotin Functional grade biotin (sterile and azide-free) Megakaryocyte/platelet markers 16 FDC Follicular dendritic cells FITC Fluorescein isothiocyanate GPI Glycophosphatidylinositol PE Phycoerythrin Gran Granulocytes ™ ™ NK/ILC markers 18 HEV High endothelial venule PE-eFluor 610 Phycoerythrin-eFluor 610 Tandem HUVEC Human umbilical vein endothelial cells PE-Cyanine5 Phycoerythrin-Cyanine5 Tandem PerCP-Cyanine5.5 Peridinin Chlorophyll Protein-Cyanine5.5 Tandem NKT/γδ T cell markers 20 HSC Hematopoietic stem cells ™ ™ IgSF Immunoglobulin superfamily PerCP-eFluor 710 Peridinin Chlorophyll Protein-eFluor 710 Tandem ILC Innate lymphoid cell PE-Cyanine7 Phycoerythrin-Cyanine7 Tandem Endothelial cell markers 22 APC Allophycocyanin Intra/Txn Intracellular/transcription factors ™ ™ kDa Kilodalton APC-eFluor 780 Allophycocyanin-eFluor 780 Stem cell markers 24 KO Knockout LAK Lymphokine activated killer Leuk Leukocytes Other cell type markers 26 LPS Lipopolysaccharide LRRF Leucine rich repeat family Human CD antigens 28 Lymph Lymphocytes Mac Macrophages MHC Major histocompatibility complex Human non-CD antigens 52 Mono Monocytes NK Natural killer Mouse CD antigens 57 PBMC Peripheral blood mononuclear pDC Plasmacytoid dendritic cell PNS Peripheral nervous system Mouse non-CD antigens 76 Human B cell markers Pan markers Follicular Marginal zone Germinal center Plasma cell Memory CD19 Surface Surface Secreted Secreted Surface CD20 CD20 CD1d IgA IgA CD27 CD22 CD21 CD9 IgE IgE IgG CD70h CD22 CD21 IgG IgG TLR1, 2, 6, 7, 10 CD79α/β CD27 CD45R (B220) Intracellular/ Surface Surface Igκ/λ CD23h CD81 transcription factor CD45R (B220) CD9 CD24 CD103 CBF1 CD81 CD19 low/neg CD40h CD180 (RP105) Pax5 CD20low/neg CD45R (B220) CD268 Intracellular/ Spi-B CD27 CD69h (BAFF receptor) transcription factor CD31 CD80h CD307d (FcRL4) AID CD38 CD81 IgM Bach2 Bcl-6 CD81 CD86h Intracellular/ IRF8 CD138 CD137 (4-1BB)h transcription factor NF-kappaB CD184 (CXCR4) CD275 (B7-H2) EBF1 Pax5 CD252 (OX40 ligand) CD279 (PD-1) Notch2 CD269 (BCMA) CD360 (IL-2 receptor) Pax5 HLA-DR Intracellular/ IgDhigh transcription factor IgMlow/int BLIMP1 IRF4 Intracellular/ XBP-1 transcription factor Bcl-6 EBF1 FoxO1 Ikaros Pax5 4 Mouse Pan markers Follicular Marginal zone Germinal center Plasma cell Memory B220 Surface Surface Surface Surface Surface CD19 CD20 CD1d CD19 CD9 CD38 CD20 CD21/CD35low/neg CD5low CD81 CD16/32 CD45R (B220)low low/neg CD21/CD35 CD22 CD9 CD95 CD19 low CD267 (TACI) CD22 CD23 CD21/CD35high GL7 CD81 CD269 (BCMA) CD23 CD24 (HSA)low CD23low/neg IgG CD138 IgG low CD24 (HSA) CD25h CD24 (HSA)low IgG Intracellular/ CD25h CD36h CD36 Intracellular/ transcription factor Intracellular/ CD36h CD40h CD81 transcription factor AID transcription factor CD40h CD69h CD180 (RP105) CBF1 Bach2 BLIMP1 CD69h CD80h CD363 (S1PR1) Spi-B Bcl-6 IRF4 CD80h CD81 FcRL3 low/neg IRF8 XBP-1 CD81 CD86h IgD high NF- B CD86h CD180 (RP105) IgM к Pax5 CD180 (RP105) CD252 (OX40 ligand)h high Intracellular/ CD252 (OX40 ligand)h IgD high low/int transcription factor IgD IgM IgMlow/int EBF1 Intracellular/ Notch2 transcription factor Bcl-6 EBF1 FoxO1 Ikaros Pax5 5 h = Upregulated i = Downregulated = Key marker = Subset B cell markers Human CD4 T cell markers Pan markers Th1 Th2 Th17 Tfh Treg CD2 Secreted Secreted Secreted Secreted Secreted CD3 IFNγ Amphiregulin GM-CSF I L-21 I L-10 CD4 I L-2 I L- 4 I L-17A TGFβ Surface CD5 TNFα I L- 5 I L-17A F CD183 (CXCR3) Surface CD7 TNFβ (LTα) I L- 9 I L-17F CD25h I L-10 I L-21 CD185 (CXCR5) CD25 CD27 Surface I L-13 I L-2 2 CD278 (ICOS) CD39 CD28 CD119 (IFNγR1) I L-21 I L-26 CD279 (PD-1) CD73 CD101 CD45RA (naïve) CD183 (CXCR3) Intracellular/ Surface Surface CD121a CD45RO (memory) CD186 (CXCR6) transcription factor CD184 (CXCR4) CD121a CD121b CD62L (naïve: high, CD191 (CCR1) BATF effector: low, CD194 (CCR4) CD161 CD137 (4-1BB) CD195 (CCR5) Bcl-6 memory: high) CD198 (CCR8) CD194 (CCR4) CD152 (CTLA-4) CD212 (IL-12Rβ1) c-Maf CD69h CD294 (CRTH2) CD196 (CCR6) CD357 (GITR/AITR) CD254 (RANKL) IRF4 CD127 (IL7Rα) CD365 (TIM1) CD360 (IL-21R) GARPh CD366 (TIM3) STAT3 CD134 (OX40)h I L-25 R ( I L-17R B ) CD212 (IL-12β1) TIGIT Intracellular/ CD137 (4-1BB)h IL-33R (ST2) I L-23 R transcription factor Intracellular/ CD152 (CTLA-4)h STAT1 Intracellular/ Intracellular/ transcription factor CD154 (CD40L)h STAT4 transcription factor transcription factor c-Rel CD272 (BTLA)h T-bet BATF AHR Eos CD279 (PD-1)h GATA-3 BATF Foxp3 IRF4 c-Maf Helios STAT6 IκBζ STAT5 IRF4 RORα RORγt STAT3 6 Mouse Pan markers Th1 Th2 Th17 Tfh Treg CD3 Secreted Secreted Secreted Secreted Secreted CD4 IFNγ Amphiregulin GM-CSF I L-21 I L-10 CD5 I L-2 I L- 4 I L-17A TGFβ TNFα I L- 5 I L-17A F Surface CD7 Surface TNFβ (LTα) I L- 9 I L-17F CD185 (CXCR5) CD25h I L-10 I L-21 CD278 (ICOS) CD25 CD27 Surface I L-13 I L-2 2 CD279 (PD-1) CD137 (4-1BB) CD39 CD28 CD94 I L-21 Intra/Txn Surface CD73 CD44h CD119 (IFNγR1) BATF CD183 (CXCR3) Surface CD194 (CCR4) CD101 CD62L (naïve: high, Bcl-6 CD186 (CXCR6) CD184 (CXCR4) CD196 (CCR6) CD121a effector: low, c-Maf CD194 (CCR4) CD121a CD121b memory: high) CD191 (CCR1) IRF4 CD195 (CCR5) CD198 (CCR8) CD212 (IL-12β1) CD152 (CTLA-4) CD69h STAT3 CD212 (IL-12Rβ1) CD294 (CRTH2) CD360 (IL-21R) CD304 (Neuropilin-1) CD127 (IL7R ) α CD218a (IL-18Rα) CD365 (TIM1) I L-23 R CD357 (GITR) CD134 (OX40)h I L-25 R ( I L-17R B ) CD254 (RANKL) Intracellular/ FR4 IL-33R (ST2) h CD137 (4-1BB)h CD366 (TIM3) transcription factor GARP TIGIT CD152 (CTLA-4)h Intracellular/ Intracellular/ AHR CD154 (CD40L)h transcription factor transcription factor BATF Intracellular/ CD272 (BTLA)h STAT1 BATF c-Maf transcription factor GATA-3 IκBζ c-Rel CD278 (ICOS)h STAT4 T-bet IRF4 IRF4 Eos CD279 (PD-1)h STAT6 RORα Foxp3 RORγt Helios STAT3 STAT5 7 h = Upregulated i = Downregulated = Key marker = Subset CD4 T cell markers Human CD8 T cell markers Pan markers Central memory Effector memory Effector Naïve CD2 Secreted Secreted Secreted Surface CD3 IFNγint Granzyme B CCL3 (MIP-1α) CD27 CD5 I L-2 int IFNγhigh CCL4 (MIP-1β) CD45RA CD7 TNFαint I L-2 low CCL5 (RANTES) CD62L CD8 Perforin Granzyme A CD127 (IL7Rα) CD25h Surface TNFαhigh Granzyme B CD197 (CCR7) low CD27 CCR7 Granzyme K Surface CD28 CD27 IFNγ CD44 CD28 I L-2 CD45RO CD45RO Perforin CD62Llow CD62L TNFα CD62Llow CD127 (IL7Rα)high CD127 (IL7Rα)high CD197 (CCR7)low Surface CD197 (CCR7)low KLRG1 CD25h KRG1high CD69h Intracellular/ CD30 transcription factor Intracellular/ CD122h Eomes transcription factor CD137 (4-1BB) T-betint Eomesint CD134 (OX40) T-betint CD223 (LAG-3) CD272 (BTLA) CD278 (ICOS) CD279 (PD-1) CD366 (TIM3) KLRG1 Intracellular/ transcription factor T-bet 8 Mouse Pan markers Central memory Effector memory Effector Naïve CD3 Secreted Secreted Secreted Surface CD5 I L- 4 low Granzyme B CCL3 (MIP-1α) CD62L CD8 IFNγlow IFNγ CCL4 (MIP-1β) C D127 ( I L-7R α) CD27 I L-2 CCL5 (RANTES) CD197 (CCR7) Granzyme A CD28 Surface Perforin CD183 (CXCR3) CD44 Granzyme B TNFα CD62L IFNγ I L-2 C D127 ( I L-7R α) Surface Perforin CD197 (CCR7)high CD44 TNFα CD57 Intracellular/ KLRG1 Surface transcription factor CD25h Intracellular/ bcl-6 CD30 int Eomes transcription factor CD44 T-betint Eomesint CD69h T-betint CD122h BLIMP1 CD134 (OX40) CD137 (4-1BB) CD223 (LAG-3) CD272 (BTLA-4) CD278 (ICOS) CD279 (PD-1) CD366 (TIM3) KLRG1 Intracellular/ transcription factor BLIMP1 Id2 T-bet 9 h = Upregulated i = Downregulated = Key marker = Subset CD8 T cell markers Human Dendritic cell markers Pan markers Conventional dendritic cell Plasmacytoid CD11b Secreted dendritic cell CD13 IDO Secreted CD33 I L-1β IFNα CD80h I L- 6 IFNβ CD83 I L- 8 I L-12 CD86h Surface I L-15 MHCIIh CD85g (ILT7) IL-23 CD123 Surface Intracellular/ CD283 (TLR3) CD1b transcription CD303 (BDCA-2) CD1c (BDCA-1) factor CD304 (BDCA-4) CD11c CD135 CD370 (CLEC9A) CD14i CD289 (TLR9) Intracellular/ CD40h Fit3 CD49d transcription factor CD141
Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB

    Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB

    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse

    Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse

    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
  • Familial Juvenile Polyposis Syndrome with a De Novo Germline Missense Variant in BMPR1A Gene: a Case Report Qing Liu, Mengling Liu, Tianshu Liu and Yiyi Yu*

    Familial Juvenile Polyposis Syndrome with a De Novo Germline Missense Variant in BMPR1A Gene: a Case Report Qing Liu, Mengling Liu, Tianshu Liu and Yiyi Yu*

    Liu et al. BMC Medical Genetics (2020) 21:196 https://doi.org/10.1186/s12881-020-01135-6 CASE REPORT Open Access Familial juvenile polyposis syndrome with a de novo germline missense variant in BMPR1A gene: a case report Qing Liu, Mengling Liu, Tianshu Liu and Yiyi Yu* Abstract Background: Juvenile polyposis syndrome (JPS) is a rare autosomal dominant hereditary disorder characterized by the development of multiple distinct juvenile polyps in the gastrointestinal tract with an increased risk of colorectal cancer. Germline mutations in two genes, SMAD4 and BMPR1A, have been identified to cause JPS. Case presentation: Here, we report a germline heterozygous missense variant (c.299G > A) in exon 3 BMPR1A gene in a family with juvenile polyposis. This variant was absent from the population database, and concluded as de novo compared with the parental sequencing. Further sequencing of the proband’s children confirmed the segregation of this variant with the disease, while the variant was also predicted to have damaging effect based on online prediction tools. Therefore, this variant was classified as likely pathogenic according to the American College of Medical Genetics and Genomics (ACMG) guidelines. Conclusions: Germline genetic testing revealed a de novo germline missense variant in BMPR1A gene in a family with juvenile polyposis. Identification of the pathogenic variant facilitates the cancer risk management of at-risk family members, and endoscopic surveillance is recommended for mutation carriers. Keywords: Juvenile polyposis syndrome, BMPR1A gene, De novo germline variant, Missense variant Background two genes, SMAD4 and BMPR1A, have been identi- Juvenile polyposis syndrome (JPS) is a rare autosomal fied to cause JPS [5].
  • Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)

    Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)

    BRIEF COMMUNICATION www.jasn.org Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron Camille Ansermet,* Matthias B. Moor,* Gabriel Centeno,* Muriel Auberson,* † † ‡ Dorothy Zhang Hu, Roland Baron, Svetlana Nikolaeva,* Barbara Haenzi,* | Natalya Katanaeva,* Ivan Gautschi,* Vladimir Katanaev,*§ Samuel Rotman, Robert Koesters,¶ †† Laurent Schild,* Sylvain Pradervand,** Olivier Bonny,* and Dmitri Firsov* BRIEF COMMUNICATION *Department of Pharmacology and Toxicology and **Genomic Technologies Facility, University of Lausanne, Lausanne, Switzerland; †Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts; ‡Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia; §School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia; |Services of Pathology and ††Nephrology, Department of Medicine, University Hospital of Lausanne, Lausanne, Switzerland; and ¶Université Pierre et Marie Curie, Paris, France ABSTRACT Tight control of extracellular and intracellular inorganic phosphate (Pi) levels is crit- leaves.4 Most recently, Legati et al. have ical to most biochemical and physiologic processes. Urinary Pi is freely filtered at the shown an association between genetic kidney glomerulus and is reabsorbed in the renal tubule by the action of the apical polymorphisms in Xpr1 and primary fa- sodium-dependent phosphate transporters, NaPi-IIa/NaPi-IIc/Pit2. However, the milial brain calcification disorder.5 How- molecular identity of the protein(s) participating in the basolateral Pi efflux remains ever, the role of XPR1 in the maintenance unknown. Evidence has suggested that xenotropic and polytropic retroviral recep- of Pi homeostasis remains unknown. Here, tor 1 (XPR1) might be involved in this process. Here, we show that conditional in- we addressed this issue in mice deficient for activation of Xpr1 in the renal tubule in mice resulted in impaired renal Pi Xpr1 in the nephron.
  • List of Genes Used in Cell Type Enrichment Analysis

    List of Genes Used in Cell Type Enrichment Analysis

    List of genes used in cell type enrichment analysis Metagene Cell type Immunity ADAM28 Activated B cell Adaptive CD180 Activated B cell Adaptive CD79B Activated B cell Adaptive BLK Activated B cell Adaptive CD19 Activated B cell Adaptive MS4A1 Activated B cell Adaptive TNFRSF17 Activated B cell Adaptive IGHM Activated B cell Adaptive GNG7 Activated B cell Adaptive MICAL3 Activated B cell Adaptive SPIB Activated B cell Adaptive HLA-DOB Activated B cell Adaptive IGKC Activated B cell Adaptive PNOC Activated B cell Adaptive FCRL2 Activated B cell Adaptive BACH2 Activated B cell Adaptive CR2 Activated B cell Adaptive TCL1A Activated B cell Adaptive AKNA Activated B cell Adaptive ARHGAP25 Activated B cell Adaptive CCL21 Activated B cell Adaptive CD27 Activated B cell Adaptive CD38 Activated B cell Adaptive CLEC17A Activated B cell Adaptive CLEC9A Activated B cell Adaptive CLECL1 Activated B cell Adaptive AIM2 Activated CD4 T cell Adaptive BIRC3 Activated CD4 T cell Adaptive BRIP1 Activated CD4 T cell Adaptive CCL20 Activated CD4 T cell Adaptive CCL4 Activated CD4 T cell Adaptive CCL5 Activated CD4 T cell Adaptive CCNB1 Activated CD4 T cell Adaptive CCR7 Activated CD4 T cell Adaptive DUSP2 Activated CD4 T cell Adaptive ESCO2 Activated CD4 T cell Adaptive ETS1 Activated CD4 T cell Adaptive EXO1 Activated CD4 T cell Adaptive EXOC6 Activated CD4 T cell Adaptive IARS Activated CD4 T cell Adaptive ITK Activated CD4 T cell Adaptive KIF11 Activated CD4 T cell Adaptive KNTC1 Activated CD4 T cell Adaptive NUF2 Activated CD4 T cell Adaptive PRC1 Activated
  • Edinburgh Research Explorer

    Edinburgh Research Explorer

    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
  • 3 Cleavage Products of Notch 2/Site and Myelopoiesis by Dysregulating

    3 Cleavage Products of Notch 2/Site and Myelopoiesis by Dysregulating

    ADAM10 Overexpression Shifts Lympho- and Myelopoiesis by Dysregulating Site 2/Site 3 Cleavage Products of Notch This information is current as David R. Gibb, Sheinei J. Saleem, Dae-Joong Kang, Mark of October 4, 2021. A. Subler and Daniel H. Conrad J Immunol 2011; 186:4244-4252; Prepublished online 2 March 2011; doi: 10.4049/jimmunol.1003318 http://www.jimmunol.org/content/186/7/4244 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2011/03/02/jimmunol.100331 Material 8.DC1 http://www.jimmunol.org/ References This article cites 45 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/186/7/4244.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 4, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology ADAM10 Overexpression Shifts Lympho- and Myelopoiesis by Dysregulating Site 2/Site 3 Cleavage Products of Notch David R.
  • The 'C3ar Antagonist' SB290157 Is a Partial C5ar2 Agonist

    The 'C3ar Antagonist' SB290157 Is a Partial C5ar2 Agonist

    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.01.232090; this version posted August 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The ‘C3aR antagonist’ SB290157 is a partial C5aR2 agonist Xaria X. Li1, Vinod Kumar1, John D. Lee1, Trent M. Woodruff1* 1School of Biomedical Sciences, The University of Queensland, St Lucia, 4072 Australia. * Correspondence: Prof. Trent M. Woodruff School of Biomedical Sciences, The University of Queensland, St Lucia, 4072 Australia. Ph: +61 7 3365 2924; Fax: +61 7 3365 1766; E-mail: [email protected] Keywords: Complement C3a, C3aR, SB290157, C5aR1, C5aR2 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.01.232090; this version posted August 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abbreviations used in this article: BRET, bioluminescence resonance energy transfer; BSA, bovine serum albumin; C3aR, C3a receptor C5aR1, C5a receptor 1; CHO-C3aR, Chinese hamster ovary cells stably expressing C3aR; CHO-C5aR1, Chinese hamster ovary cells stably expressing C5aR1; DMEM, Dulbecco's Modified Eagle's Medium; ERK1/2, extracellular signal-regulated kinase 1/2; FBS, foetal bovine serum; HEK293, human embryonic kidney 293 cells; HMDM, human monocyte-derived macrophage; i.p., intraperitoneal; i.v., intravenous; rhC5a, recombinant human C5a; RT, room temperature; S.E.M.
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation

    4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation

    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
  • ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease

    ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease

    International Journal of Molecular Sciences Review ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease Francesca Tosetti 1,* , Massimo Alessio 2, Alessandro Poggi 1,† and Maria Raffaella Zocchi 3,† 1 Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico S. Martino Largo R. Benzi 10, 16132 Genoa, Italy; [email protected] 2 Proteome Biochemistry, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; [email protected] 3 Division of Immunology, Transplants and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work as last author. Abstract: Enzymes, once considered static molecular machines acting in defined spatial patterns and sites of action, move to different intra- and extracellular locations, changing their function. This topological regulation revealed a close cross-talk between proteases and signaling events involving post-translational modifications, membrane tyrosine kinase receptors and G-protein coupled recep- tors, motor proteins shuttling cargos in intracellular vesicles, and small-molecule messengers. Here, we highlight recent advances in our knowledge of regulation and function of A Disintegrin And Metalloproteinase (ADAM) endopeptidases at specific subcellular sites, or in multimolecular com- plexes, with a special focus on ADAM10, and tumor necrosis factor-α convertase (TACE/ADAM17), since these two enzymes belong to the same family, share selected substrates and bioactivity. We will discuss some examples of ADAM10 activity modulated by changing partners and subcellular compartmentalization, with the underlying hypothesis that restraining protease activity by spatial Citation: Tosetti, F.; Alessio, M.; segregation is a complex and powerful regulatory tool.
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation

    Transcriptional Control of Tissue-Resident Memory T Cell Generation

    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
  • Cell-Autonomous FLT3L Shedding Via ADAM10 Mediates Conventional Dendritic Cell Development in Mouse Spleen

    Cell-Autonomous FLT3L Shedding Via ADAM10 Mediates Conventional Dendritic Cell Development in Mouse Spleen

    Cell-autonomous FLT3L shedding via ADAM10 mediates conventional dendritic cell development in mouse spleen Kohei Fujitaa,b,1, Svetoslav Chakarovc,1, Tetsuro Kobayashid, Keiko Sakamotod, Benjamin Voisind, Kaibo Duanc, Taneaki Nakagawaa, Keisuke Horiuchie, Masayuki Amagaib, Florent Ginhouxc, and Keisuke Nagaod,2 aDepartment of Dentistry and Oral Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan; bDepartment of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan; cSingapore Immunology Network, Agency for Science, Technology and Research, Biopolis, 138648 Singapore; dDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892; and eDepartment of Orthopedic Surgery, National Defense Medical College, Tokorozawa 359-8513, Japan Edited by Kenneth M. Murphy, Washington University School of Medicine, St. Louis, MO, and approved June 10, 2019 (received for review November 4, 2018) Conventional dendritic cells (cDCs) derive from bone marrow (BM) intocDC1sorcDC2stakesplaceintheBM(3),andthese precursors that undergo cascades of developmental programs to pre-cDC1s and pre-cDC2s ultimately differentiate into cDC1s terminally differentiate in peripheral tissues. Pre-cDC1s and pre- and cDC2s after migrating to nonlymphoid and lymphoid tissues. + + cDC2s commit in the BM to each differentiate into CD8α /CD103 cDCs are short-lived, and their homeostatic maintenance relies + cDC1s and CD11b cDC2s, respectively. Although both cDCs rely on on constant replenishment from the BM precursors (5). The cy- the cytokine FLT3L during development, mechanisms that ensure tokine Fms-related tyrosine kinase 3 ligand (FLT3L) (12), by cDC accessibility to FLT3L have yet to be elucidated. Here, we gen- signaling through its receptor FLT3 expressed on DC precursors, erated mice that lacked a disintegrin and metalloproteinase (ADAM) is essential during the development of DCs (7, 13).